J. Barrett

Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults.

D. Graham, G. Lyon, D. Bernstein, 2015, The Journal of infectious diseases.

Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical study

R. Levy, S. Reddy, S. Garger, 2008, Proceedings of the National Academy of Sciences.

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules

Andrea A. Berry, K. Edwards, E. Walter, 2016, Pediatrics.

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Alison E Kosel, K. Meyer, M. Robb, 2017, The Lancet.

Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood

M. Mulligan, W. Keitel, Shital M. Patel, 2018, Open forum infectious diseases.

Serological Correlates of Protection against a GII.4 Norovirus

D. Graham, G. Lyon, D. Bernstein, 2015, Clinical and Vaccine Immunology.

Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules

Andrea A. Berry, K. Edwards, E. Walter, 2016, Pediatrics.